These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

332 related items for PubMed ID: 22693566

  • 1. Receptor-targeting phthalocyanine photosensitizer for improving antitumor photocytotoxicity.
    Xu P, Chen J, Chen Z, Zhou S, Hu P, Chen X, Huang M.
    PLoS One; 2012; 7(5):e37051. PubMed ID: 22693566
    [Abstract] [Full Text] [Related]

  • 2. A Nanoencapsulated Ir(III)-Phthalocyanine Conjugate as a Promising Photodynamic Therapy Anticancer Agent.
    Bonelli J, Ortega-Forte E, Vigueras G, Follana-Berná J, Ashoo P, Abad-Montero D, Isidro N, López-Corrales M, Hernández A, Ortiz J, Izquierdo-García E, Bosch M, Rocas J, Sastre-Santos Á, Ruiz J, Marchán V.
    ACS Appl Mater Interfaces; 2024 Jul 31; 16(30):38916-38930. PubMed ID: 39041453
    [Abstract] [Full Text] [Related]

  • 3. Lenvatinib-zinc phthalocyanine conjugates as potential agents for enhancing synergistic therapy of multidrug-resistant cancer by glutathione depletion.
    Wei G, Huang L, Jiang Y, Shen Y, Huang Z, Huang Y, Sun X, Zhao C.
    Eur J Med Chem; 2019 May 01; 169():53-64. PubMed ID: 30856406
    [Abstract] [Full Text] [Related]

  • 4. Novel zinc phthalocyanine as a promising photosensitizer for photodynamic treatment of esophageal cancer.
    Kuzyniak W, Schmidt J, Glac W, Berkholz J, Steinemann G, Hoffmann B, Ermilov EA, Gürek AG, Ahsen V, Nitzsche B, Höpfner M.
    Int J Oncol; 2017 Mar 01; 50(3):953-963. PubMed ID: 28098886
    [Abstract] [Full Text] [Related]

  • 5. Transport of Zinc-Phthalocyanine to Cancer Cells Using Myoglobin-Albumin Fusion Protein for Photodynamic Therapy.
    Yamada T, Funamoto M, Takada R, Morita Y, Komatsu T.
    Chembiochem; 2024 Sep 02; 25(17):e202400329. PubMed ID: 38926093
    [Abstract] [Full Text] [Related]

  • 6. Enhanced photodynamic efficacy of zinc phthalocyanine by conjugating to heptalysine.
    Li L, Luo Z, Chen Z, Chen J, Zhou S, Xu P, Hu P, Wang J, Chen N, Huang J, Huang M.
    Bioconjug Chem; 2012 Nov 21; 23(11):2168-72. PubMed ID: 23057652
    [Abstract] [Full Text] [Related]

  • 7. Monomer zinc phthalocyanine/upconversion nanoparticle coated with hyaluronic acid crosslinked gel as NIR light-activated drug for in vitro photodynamic therapy.
    Zhou L, Chen E, Jin W, Wang Y, Zhou J, Wei S.
    Dalton Trans; 2016 Sep 27; 45(38):15170-15179. PubMed ID: 27711660
    [Abstract] [Full Text] [Related]

  • 8. Fully protected glycosylated zinc (II) phthalocyanine shows high uptake and photodynamic cytotoxicity in MCF-7 cancer cells.
    Kimani SG, Shmigol TA, Hammond S, Phillips JB, Bruce JI, MacRobert AJ, Malakhov MV, Golding JP.
    Photochem Photobiol; 2013 Sep 27; 89(1):139-49. PubMed ID: 22803957
    [Abstract] [Full Text] [Related]

  • 9. Photodynamic therapy of hepatocellular carcinoma using tetra-triethyleneoxysulfonyl zinc phthalocyanine as photosensitizer.
    Ogbodu RO, Nitzsche B, Ma A, Atilla D, Gürek AG, Höpfner M.
    J Photochem Photobiol B; 2020 Jul 27; 208():111915. PubMed ID: 32480203
    [Abstract] [Full Text] [Related]

  • 10. Tetra-triethyleneoxysulfonyl substituted zinc phthalocyanine for photodynamic cancer therapy.
    Kuzyniak W, Ermilov EA, Atilla D, Gürek AG, Nitzsche B, Derkow K, Hoffmann B, Steinemann G, Ahsen V, Höpfner M.
    Photodiagnosis Photodyn Ther; 2016 Mar 27; 13():148-157. PubMed ID: 26162500
    [Abstract] [Full Text] [Related]

  • 11. Receptor-mediated targeting of a photosensitizer by its conjugation to gonadotropin-releasing hormone analogues.
    Rahimipour S, Ben-Aroya N, Ziv K, Chen A, Fridkin M, Koch Y.
    J Med Chem; 2003 Sep 11; 46(19):3965-74. PubMed ID: 12954050
    [Abstract] [Full Text] [Related]

  • 12. A tumor-targeted Ganetespib-zinc phthalocyanine conjugate for synergistic chemo-photodynamic therapy.
    Huang L, Wei G, Sun X, Jiang Y, Huang Z, Huang Y, Shen Y, Xu X, Liao Y, Zhao C.
    Eur J Med Chem; 2018 May 10; 151():294-303. PubMed ID: 29627724
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. Attritional evaluation of lipophilic and hydrophilic metallated phthalocyanines for oncological photodynamic therapy.
    Dias LM, Sharifi F, de Keijzer MJ, Mesquita B, Desclos E, Kochan JA, de Klerk DJ, Ernst D, de Haan LR, Franchi LP, van Wijk AC, Scutigliani EM, Cavaco JEB, Tedesco AC, Huang X, Pan W, Ding B, Krawczyk PM, Heger M, Photodynamic Therapy Study Group.
    J Photochem Photobiol B; 2021 Mar 10; 216():112146. PubMed ID: 33601256
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. Pentalysine beta-carbonylphthalocyanine zinc: an effective tumor-targeting photosensitizer for photodynamic therapy.
    Chen Z, Zhou S, Chen J, Deng Y, Luo Z, Chen H, Hamblin MR, Huang M.
    ChemMedChem; 2010 Jun 07; 5(6):890-8. PubMed ID: 20458713
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. Photodynamic Therapy with Liposomal Zinc Phthalocyanine and Tirapazamine Increases Tumor Cell Death via DNA Damage.
    Broekgaarden M, Weijer R, van Wijk AC, Cox RC, Egmond MR, Hoebe R, van Gulik TM, Heger M.
    J Biomed Nanotechnol; 2017 Feb 07; 13(2):204-20. PubMed ID: 29377650
    [Abstract] [Full Text] [Related]

  • 19. Anti-Psoriasis Effects and Mechanisms of Α-(8-Quinolinoxy) Zinc Phthalocyanine-Mediated Photodynamic Therapy.
    Liu HQ, Wang YM, Li WF, Li C, Jiang ZH, Bao J, Wei JF, Jin HT, Wang AP.
    Cell Physiol Biochem; 2017 Feb 07; 44(1):200-214. PubMed ID: 29131032
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 17.